First Patient Dosed in CANbridge Pharmaceuticals CAN103 Phase 2 Trial for the Treatment of Gaucher Disease in ChinaBusiness Wire • 01/19/23
General Dynamics to Webcast 2022 Fourth-Quarter and Full-Year Financial Results Conference CallPRNewsWire • 01/06/23
General Dynamics Electric Boat Awarded $5.1 billion by U.S. Navy for Columbia-Class SubmarinesPRNewsWire • 12/21/22
General Dynamics Appoints Aiken as Executive Vice President and CFO; Marzilli to RetirePRNewsWire • 12/19/22
General Dynamics (GD) Up 1.7% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/25/22